Suppr超能文献

滋肾生血方对长期血液透析肾性贫血患者内源性促红细胞生成素的影响

[Effect of zishen shengxue recipe on endogenous erythropoietin in patients with renal anemia undergoing long-term hemodialysis].

作者信息

Tan Jin-chuan, Hu Jin-huan, Su Jing-wen

机构信息

Department of Renal Medicine, Chinese Medical Hospital of Hebei Medical University, Shijiazhuang 050011.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Jan;30(1):42-4.

Abstract

OBJECTIVE

To investigate the mechanism of Zishen Shengxue Recipe (ZSR) in treating renal anemia by observing its effect on serum level of endogenous erythropoietin in patients undergoing long-term hemodialysis.

METHODS

Sixty renal anemia patients undergoing long-term hemodialysis were randomly and equally assigned to two groups. The treated group was treated with subcutaneous injection of erythropoiesis stimulating factor (rHuEpo) combined with oral intake of ZSR, and the control group treated with rHuEpo alone. They were observed for eight weeks, and the blood levels of endogenous human erythropoietin (Epo), hemoglobin (Hgb), hematocrit (Hct), as well as the residual renal function (RRF) in the two groups were compared.

RESULTS

Serum Epo level in the control group was unchanged after treatment (P>0.05), while that in the treated group increased significantly, and showed significant difference in comparing with that in the control group (P<0.05). Levels of Hgb and Hct increased and RRF decreased in both groups (P<0.01), but the treated group showed higher increments and lesser decrement than those in the control group (P<0.05).

CONCLUSIONS

ZSR can enhance the blood levels of Hgb, Hct and Epo, postpone the descent of RRF, and correct the anemic status in patients. Its mechanism of action is possibly through alleviating the inhibition of uremic toxin on erythropoiesis, in the meanwhile of promoting the secretion of Epo.

摘要

目的

通过观察滋肾生血方(ZSR)对长期血液透析患者内源性促红细胞生成素血清水平的影响,探讨其治疗肾性贫血的机制。

方法

将60例长期血液透析的肾性贫血患者随机等分为两组。治疗组采用皮下注射促红细胞生成刺激因子(rHuEpo)联合口服ZSR治疗,对照组仅采用rHuEpo治疗。观察8周,比较两组内源性人促红细胞生成素(Epo)、血红蛋白(Hgb)、血细胞比容(Hct)的血药浓度以及残余肾功能(RRF)。

结果

对照组治疗后血清Epo水平无变化(P>0.05),而治疗组血清Epo水平显著升高,与对照组比较差异有统计学意义(P<0.05)。两组Hgb和Hct水平均升高,RRF均降低(P<0.01),但治疗组升高幅度和降低幅度均优于对照组(P<0.05)。

结论

滋肾生血方可提高患者的Hgb、Hct和Epo血药浓度,延缓RRF下降,纠正患者贫血状态。其作用机制可能是通过减轻尿毒症毒素对红细胞生成的抑制,同时促进Epo的分泌。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验